TotalMarketCap

Dr Reddys Laboratories

RDYNYSE IndiaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.225 B

$12.25 -2.93%

Close of 2 Oct 2026

As of 2 Oct 2026, Dr Reddys Laboratories (RDY) has a market capitalization of $10.2B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

834,656,970

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #31Biomarin PharmaceuticalBMRN$11.3B
  2. #32Elanco Animal HealthELAN$10.9B
  3. #33Dr Reddys LaboratoriesRDY$10.2B
  4. #34Axsome TherapeuticsAXSM$9.54B
  5. #35Arrowhead PharmaceuticalsARWR$9.15B

What if Dr Reddys Laboratories were worth as much as…

Open the what-if tool →

Gold $28.8T

$34,518.32

Per share 2,818× higher

Bitcoin $1.70T

$2,037.27

Per share 166× higher

Nvidia $5.56T

$6,665.88

Per share 544× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Dr Reddys Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 3 Oct 2026. Read the methodology.